Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer.
about
Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector.Adeno-associated virus (AAV) vectors in cancer gene therapy.Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.
P2860
Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@ast
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@en
type
label
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@ast
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@en
prefLabel
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@ast
Oral vaccination with adeno-as ...... rowth of murine breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Oral vaccination with adeno-as ...... growth of murine breast cancer
@en
P2093
Charmaine A Ramlogan
Giovanni Di Pasquale
John A Chiorini
John C Morris
Vyomesh Patel
P2860
P304
P356
10.1038/MT.2012.260
P577
2013-01-08T00:00:00Z